ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.31
0.00%
US Tech 100
20,755.60
0.47%
S&P 500
5,872.16
-2.95%
US Dollar vs CAD
1.43855
-0.53%
Bitcoin
102,441.56
2.38%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) News

CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMND
DateTimeSourceHeadlineSymbolCompany
12/16/20247:37AMGlobeNewswire Inc.Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ FormatNASDAQ:CMNDClearmind Medicine Inc
12/09/20244:12PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMNDClearmind Medicine Inc
12/06/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
11/20/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
10/10/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
10/10/20247:07AMGlobeNewswire Inc.Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical SiteNASDAQ:CMNDClearmind Medicine Inc
09/30/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMNDClearmind Medicine Inc
09/26/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
09/24/20243:30PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CMNDClearmind Medicine Inc
09/16/20243:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
09/16/20243:06PMGlobeNewswire Inc.Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination TherapyNASDAQ:CMNDClearmind Medicine Inc
09/16/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
09/12/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
09/12/20247:20AMGlobeNewswire Inc.Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
09/06/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
09/06/20246:55AMGlobeNewswire Inc.Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
09/06/20246:55AMGlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
08/29/20243:25PMGlobeNewswire Inc.Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
08/21/20243:11PMGlobeNewswire Inc.Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior TreatmentNASDAQ:CMNDClearmind Medicine Inc
08/16/20243:14PMGlobeNewswire Inc.Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental DisordersNASDAQ:CMNDClearmind Medicine Inc
08/06/20247:57AMGlobeNewswire Inc.Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss DrugNASDAQ:CMNDClearmind Medicine Inc
08/06/20247:57AMGlobeNewswire Inc.SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss DrugNASDAQ:CMNDClearmind Medicine Inc
07/31/20246:44AMGlobeNewswire Inc.Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking ResearchNASDAQ:CMNDClearmind Medicine Inc
07/19/20246:55AMGlobeNewswire Inc.Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage ProductNASDAQ:CMNDClearmind Medicine Inc
07/16/20248:02AMGlobeNewswire Inc.Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for AlcoholismNASDAQ:CMNDClearmind Medicine Inc
07/16/20245:03AMGlobeNewswire Inc.SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight LossNASDAQ:CMNDClearmind Medicine Inc
07/16/20245:03AMGlobeNewswire Inc.Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-lossNASDAQ:CMNDClearmind Medicine Inc
07/12/20247:02AMGlobeNewswire Inc.Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 ConferenceNASDAQ:CMNDClearmind Medicine Inc
06/28/20246:55AMGlobeNewswire Inc.Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors TreatmentNASDAQ:CMNDClearmind Medicine Inc
06/20/20246:57AMGlobeNewswire Inc.Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:CMND

Your Recent History

BIT
UV4M4E
UniCredit Bank
AQSE
XDJP.GB
Deutsche Bank Luxembourg
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved